Literature DB >> 5301928

[Further studies on the in vitro demonstration of cell-bound antibodies in tuberculosis with reference to the clinical aspects and humoral antibodies against tuberculin].

H Wuttke, I Wuttke-Görnandt, O Haferkamp.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1967        PMID： 5301928

Source DB:  PubMed          Journal:  Virchows Arch Pathol Anat Physiol Klin Med        ISSN： 0376-0081


× No keyword cloud information.
  6 in total

1.  [IMMUNOLOGIC PRINCIPLES OF REMOTE ALLERGIC REACTION].

Authors:  G GILLISSEN
Journal:  Klin Wochenschr       Date:  1965-06-01

2.  Tuberculin-induced mitosis in peripheral blood leucocytes.

Authors:  G PEARMAIN; R R LYCETTE; P H FITZGERALD
Journal:  Lancet       Date:  1963-03-23       Impact factor: 79.321

3.  Mitogenic action of phytohaemagglutinin.

Authors:  K HIRSCHHORN; R L KOLODNY; N HASHEM; F BACH
Journal:  Lancet       Date:  1963-08-10       Impact factor: 79.321

4.  [On the demonstration of cell-bound antibodies in vitro].

Authors:  H Schäfer; H Wuttke; O Haferkamp
Journal:  Virchows Arch Pathol Anat Physiol Klin Med       Date:  1966-06-21

5.  Inhibition of tuberculin-induced mitogenesis in cultures of lymphocytes from tuberculous donors.

Authors:  D H Heilman; W McFarland
Journal:  Int Arch Allergy Appl Immunol       Date:  1966

6.  Suppression of allergic encephalomyelitis in rats by means of antibrain serum.

Authors:  P Y PATERSON; S M HARWIN
Journal:  J Exp Med       Date:  1963-05-01       Impact factor: 14.307
  6 in total
  2 in total

1.  [Lymphocyte transformation in vitro in tuberculosis].

Authors:  P G Scheurlen; A Pappas; D Wegener
Journal:  Klin Wochenschr       Date:  1969-08-01

2.  [On the quantitative functional analysis of an inhibitory factor for lymphocyte transformation in cell cultures following tuberculin addition in the blood plasma of patients suffering from tuberculosis].

Authors:  H Wuttke; I Wuttke-Görnandt; O Haferkamp
Journal:  Klin Wochenschr       Date:  1968-07-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.